Skip to content
Friday, March 24, 2023
HealthCare Middle East & Africa Logo 500

No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa

  • HOME
  • TOPICS
    • MERGERS, INVESTMENTS & FUNDING
    • DISEASES UPDATES
    • HOSPITALS
    • PHARMACEUTICALS
    • PEOPLE NEWS
  • THE MAGAZINE
    • About HealthCare Middle East & Africa Magazine
    • PRESS RELEASES
    • SUBSCRIBE TO EMAIL NEWSLETTERS
  • ADVERTISE
  • PROFILES & INTERVIEWS
  • OUR EVENTS
  • CONTACT US
BREAKING NEWS
  • UAE-based AstraGene and Mylab form joint venture to commercialize automated diagnostics
  • Chinese missionaries in Rwanda perform painless normal delivery
  • <strong>OSHCO, VAMED Group to establish a new rehabilitation & long-term care hospital in Riyadh</strong>
  • Uganda launches project to scale up paediatric surgical services in hospitals
  • <strong>Dubai’s state-owned DAHC, Pfizer, AXDEV Group ally to enhance chronic illness care</strong>
  • Macra supports Ministry of Health with US$53,296 cholera materials
  • KFSH&RC to debut its Digital Health Conference in Riyadh
  • NPHCDA launches project to prevent maternal health challenges
  • <strong>Saudi’s KAEC inks health cooperation pact with Dr. Sulaiman Al Habib Medical Group</strong>
  • Africa has the highest global surge in oral diseases - WHO
You are here
  • Home
  • Moderna

Tag: Moderna

Moderna gears up for worldwide recruitment drive, expands presence across the United States

13 March 202313 March 2023

USA — Moderna, the mRNA vaccine and therapeutics developer, has announced its growth plans, which include global expansion and the hiring of approximately 2,000 new employees worldwide by the end…

Read More

Moderna expands operations to Oxfordshire with new research and manufacturing site

8 March 20239 March 2023

UNITED KINGDOM — Moderna has announced that it will construct a new research and manufacturing site, the Moderna Innovation and Technology Center (MITC), in Oxfordshire, UK. The MITC will be…

Read More

Mixed results for Moderna’s influenza mRNA vaccine candidate

21 February 202321 February 2023

USA — Moderna, a US biotech firm has announced mixed findings from a large-scale trial of its mRNA flu shot, which employs the same technology as its effective Covid-19 vaccine.…

Read More

Moderna looks to expand its manufacturing footprint globally  

22 January 202322 January 2023

USA — Moderna CEO Stéphane Bancel stated this week at the World Economic Forum Annual Meeting that the company intends to build on its exponential growth during the pandemic by…

Read More

Moderna RSV vaccine shows 84% efficacy in preventing symptoms in older adults, pitting it in a race with GSK, Pfizer

19 January 202319 January 2023

USA — Moderna has announced that its experimental messenger RNA vaccine for respiratory syncytial virus (RSV) was 83.7% effective in preventing at least two symptoms, such as cough and fever,…

Read More

Moderna to acquire Japanese DNA manufacturer OriCiro for US$85M

7 January 20239 January 2023

JAPAN – Moderna Inc. has struck a deal to buy OriCiro Genomics K.K., a pioneer in cell-free DNA synthesis and amplification technologies, for US$85 million in cash. The biotechnology company…

Read More

Moderna strikes US$35M scientific research deal with Cytomx

7 January 20239 January 2023

USA – Moderna Inc. has entered into a strategic collaboration and licensing pact worth up to US$35 million with CytomX Therapeutics Inc., a leader in the field of conditionally activated…

Read More

Moderna’s mRNA cancer vaccine shows promise in early trial with Merck’s Keytruda

15 December 202216 December 2022

USA —A personalized Moderna Inc. cancer vaccine combined with collaborator Merck & Co.’s best-selling drug reduced melanoma deaths in a mid-stage trial, easing concerns about the biotechnology company’s second act…

Read More

Merck and Moderna to jointly develop and sell cancer vaccine

18 October 202218 October 2022

USA — Merck & Co. has exercised a US$250-million option with Moderna to jointly develop and commercialize personalized mRNA cancer vaccine candidates. Merck & Co. will pay Moderna US$250 million…

Read More

FDA authorizes COVID-19 vaccines for use as a booster dose in kids as young as 5

16 October 202216 October 2022

USA – The United States FDA (US FDA) has authorized updated COVID-19 boosters for children as young as five, seeking to broaden protection ahead of an expected winter storm. The…

Read More

Posts navigation

Older posts

LATEST DIGITAL MAGAZINE

LATEST NEWS

  • UAE-based AstraGene and Mylab form joint venture to commercialize automated diagnostics
  • Chinese missionaries in Rwanda perform painless normal delivery
  • OSHCO, VAMED Group to establish a new rehabilitation & long-term care hospital in Riyadh
  • Uganda launches project to scale up paediatric surgical services in hospitals
  • Dubai’s state-owned DAHC, Pfizer, AXDEV Group ally to enhance chronic illness care

MOST POPULAR TAGS

Africa Africa CDC Artificial Intelligence AstraZeneca Cancer Covid-19 Diabetes Digital health Egypt France Germany Ghana GSK Healthcare Delivery HIV/AIDS Hospitals India Japan Johnson & Johnson Kenya Malaria Merck Mergers, Investments & Funding Middle East and North Africa Moderna MOH Kenya Nigeria Novartis Partnerships Pfizer Pharmaceuticals Public Health Roche Science & Technology South Africa Switzerland Tanzania UAE Uganda UK UNICEF USA US FDA Vaccines WHO

ARCHIVES

ABOUT FW AFRICA

We organise some of the most impactful face to face and virtual trade events and publish leading magazines and websites that bring Africa to the World and the World to Africa. We believe that when people come together, networks grow and businesses thrive.

Find more about us on our corporate website www.fwafrica.net

RELATED PUBLICATIONS

CEO Business Africa

Food Business Africa

Food Safety Africa

Milling & Baking Africa

Sustainable Packaging Africa

CONTACT US

FW Africa

P.O. Box 1874-00621, Nairobi, Kenya

Tel: +254 725 34 39 32

Email: info@fwafrica.net

Copyright © All rights reserved. FW Africa. We are not responsible for content from external sites.